Wellesley, MA, United States of America

Ramil F Latypov

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Seattle, WA (US) (2016)
  • Wellesley, MA (US) (2019 - 2022)

Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ramil F Latypov: Innovator in Pharmaceutical Compositions

Introduction

Ramil F Latypov is a notable inventor based in Wellesley, MA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work primarily focuses on innovative compositions that enhance therapeutic efficacy.

Latest Patents

Latypov's latest patents include a pharmaceutical composition comprising bispecific antibody constructs. This invention provides novel and stable pharmaceutical compositions that include bispecific single chain antibody constructs, cyclodextrins, and a buffer. Another significant patent is for lyophilized therapeutic peptibody formulations, which offers long-term stable formulations of a lyophilized therapeutic peptibody and methods for creating such compositions.

Career Highlights

Throughout his career, Ramil F Latypov has worked with prominent companies in the pharmaceutical industry, including Amgen Inc. and Amgen Research (Munich) GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug formulation.

Collaborations

Latypov has collaborated with esteemed colleagues such as William Callahan and Richard L Remmele, Jr. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Ramil F Latypov stands out as a significant figure in the pharmaceutical industry, with a focus on innovative compositions that improve therapeutic outcomes. His contributions through patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…